Showing results (591-600 of 908) with videos related to
Sort By:
Pageof 91
Paediatric and Perinatal Epidemiology|April 1, 1997
A cohort study of pregnancy outcome after amniocentesis in twin pregnancyS A Kidd, P A Lancaster, J C Anderson, et al.Journal of Acquired Immune Deficiency Syndromes|January 1, 1990
The importance of confounding factors in the evaluation of neuropsychological changes in patients infected with human immunodeficiency virusJ W Wilkins, K R Robertson, C van der Horst, et al.Clinical Breast Cancer|December 3, 2014
A good drug made better: the fulvestrant dose-response storyJohn F R Robertson, Justin Lindemann, Sally Garnett, et al.Clinical Trials (London, England)|August 24, 2022
Importance of patient engagement in the conduct of pragmatic multicenter randomized controlled trials: The ADAPTABLE experienceGuillaume Marquis-Gravel, Madelaine Faulkner, Greg Merritt, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2025
Fulvestrant Versus Anastrozole in Endocrine Therapy-Naïve Women With Hormone Receptor-Positive Advanced Breast Cancer: Final Overall Survival in the Phase III FALCON TrialJohn F R Robertson, Zhimin Shao, Shinzaburo Noguchi, et al.Chemistryopen|January 11, 2018
Extending the Scope of 19F Hyperpolarization through Signal Amplification by Reversible Exchange in MRI and NMR SpectroscopyAlexandra M Olaru, Thomas B R Robertson, Jennifer S Lewis, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|February 10, 2007
Assessing health-related quality of life in NeuroAIDS: some psychometric properties of the Neurological Quality of Life Questionnaire (NeuroQOL)Kevin R Robertson, Thomas D Parsons, Steven A Rogers, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2009
Activity of fulvestrant 500 mg versus anastrozole 1 mg as first-line treatment for advanced breast cancer: results from the FIRST studyJohn F R Robertson, Antonio Llombart-Cussac, Janusz Rolski, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1990
Pediatric osteosarcoma: therapeutic strategies, results, and prognostic factors derived from a 10-year experienceM Hudson, M R Jaffe, N Jaffe, et al.BMC Public Health|November 21, 2018
Determinants of motivation to quit in smokers screened for the early detection of lung cancer: a qualitative studyBen Young, Kavita Vedhara, Denise Kendrick, et al.Pageof 91